Jazz's narcolepsy treatment passes Phase 3 test

Submitted by admin on March 27, 2019 - 11:39am

Source:

Biopharma Dive

News Tags:

Headline:

snippet:

Cowen & Co. says it's possible Jazz's blockbuster Xyrem franchise could be fully converted to this new drug if it gains approval.

Search form